Companies in the neuroscience sector developing innovative solutions and technologies.
Explore 340 recently funded neuroscience companies with verified founder contact information and fundraising data.
LIFESCAPES develops Brain-Machine Interface technology to support rehabilitation for patients with severe paralysis following strokes.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.
Cognixion is a neural interface startup creates AI-powered products for individuals with disabilities.
NeuroGyn develops neurostimulation systems and minimally invasive neuromodulation procedures for treating pelvic and systemic disorders.
MintNeuro is a semiconductor company developing integrated circuits for neural devices and neurotechnology applications.
Precision Neuroscience develops brain-computer interfaces for people with paralysis.
Anacalypsis Therapeutics is a biotechnology company that develops medications and biomarkers for neurodegenerative diseases.
UCANACT is a digital assistive technology paired with wearables or implants to give motor-disabled individuals control over digital devices.
Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.
AiM Medical Robotics is a biotechnology company developing a robotic system for use in neurosurgical procedures.
Bewelab is the first neuroscience-based digital intervention targeting cravings at the neural level.
Leal Therapeutics develops novel therapeutics for patients.
Archean Sciences builds AI-powered biological systems to decode the brain and accelerate discovery through autonomous experimentation.
Aiforia’s mission is to provide global access to AI-powered image analysis for medical, healthcare professionals and beyond.
Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
SKILLCOURT provides a sensor-based diagnostic and training system for visual, cognitive, and motor skills.
Sharper Sense is a wearable patch that stimulates a neck nerve to improve hearing, vision, and touch.
NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.
The neuroscience sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Neuroscience companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The neuroscience sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 340 neuroscience companies tracked in the VCBacked database.
Companies in the neuroscience sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting neuroscience companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked